News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biophage Pharma Inc. Announces Commercial Launch of Titanium Hypersensitivity Detection Test at Mini Symposium on the Effect of Toxic Metals and Nanoparticles on Human Health


12/6/2007 2:45:03 PM

MONTREAL, Dec. 6 /CNW Telbec/ - (TSX.V: BUG) - Biophage Pharma is very pleased to announce today the commercial launch of a new test for the detection of titanium hypersensitivity during a mini symposium held in Montreal on the effect of toxic metals and nanoparticles on human health. Co-hosted by Biophage Pharma and the MELISA(R) Foundation, this Mini Symposium was presented by Professor Vera Stejskal, inventor of the MELISA(R) technology. Invited guests were given a tour of Biophage ImmunotoxLabs and were able to interact with its scientists.

Read at Canada NewsWire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES